![Amy Levin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Amy Levin formerly worked at Roche Molecular Systems, Inc., as Director-International Regulatory Affairs from 2015 to 2022 and Mainz Biomed NV, as Vice President-Regulatory Affairs.
| Unternehmen | Position | Ende |
|---|---|---|
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | General Counsel | 01.05.2022 |
| QUANTUM CYBER N.V. | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Roche Molecular Systems, Inc.
Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
Mainz Biomed NV
 Mainz Biomed NV BiotechnologyHealth Technology Operates as a molecular genetics cancer diagnostic company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
